CMU researchers have published in Science a new 3D bioprinting method that brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
A team of researchers from Carnegie Mellon University has published a paper in Science that details a new technique allowing anyone to 3D bioprint tissue scaffolds out of collagen, the major structural protein in the human body. This first-of-its-kind method brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
The technique, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), has allowed the researchers to overcome many challenges associated with existing 3D bioprinting methods, and to achieve unprecedented resolution and fidelity using soft and living materials.
Each of the organs in the human body, such as the heart, is built from specialized cells that are held together by a biological scaffold called the extracellular matrix (ECM). This network of ECM proteins provides the structure and biochemical signals that cells need to carry out their normal function. However, until now it has not been possible to rebuild this complex ECM architecture using traditional biofabrication methods.
What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle.
Adam Feinberg, Professor, Biomedical Engineering and Materials Science & Engineering
“What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle,” says Adam Feinberg, a professor of biomedical engineering (BME) and materials science & engineering, whose lab performed this work. “By using MRI data of a human heart, we were able to accurately reproduce patient-specific anatomical structure and 3D bioprint collagen and human heart cells.”
Over 4,000 patients in the United States are waiting for a heart transplant, while millions of others worldwide need hearts but are ineligible for the waitlist. The need for replacement organs is immense, and new approaches are needed to engineer artificial organs that are capable of repairing, supplementing, or replacing long-term organ function. Feinberg, who is a member of Carnegie Mellon’s Bioengineered Organs Initiative and the Next Manufacturing Center, is working to solve these challenges with a new generation of bioengineered organs that more closely replicate natural organ structures.
“Collagen is an extremely desirable biomaterial to 3D print with because it makes up literally every single tissue in your body,” explains Andrew Hudson, a BME Ph.D. student in Feinberg’s lab and co-first author on the paper. “What makes it so hard to 3D print, however, is that it starts out as a fluid—so if you try to print this in air it just forms a puddle on your build platform. So we’ve developed a technique that prevents it from deforming.”
The FRESH 3D bioprinting method developed in Feinberg’s lab allows collagen to be deposited layer-by-layer within a support bath of gel, giving the collagen a chance to solidify in place before it is removed from the support bath. With FRESH, the support gel can be easily melted away by heating the gel from room temperature to body temperature after the print is complete. This way, the researchers can remove the support gel without damaging the printed structure made of collagen or cells.
This method is truly exciting for the field of 3D bioprinting because it allows collagen scaffolds to be printed at the large scale of human organs. And it is not limited to collagen, as a wide range of other soft gels including fibrin, alginate, and hyaluronic acid can be 3D bioprinted using the FRESH technique, providing a robust and adaptable tissue engineering platform. Importantly, the researchers also developed open-source designs so that nearly anyone, from medical labs to high school science classes, can build and have access to low-cost, high-performance 3D bioprinters.
Looking forward, FRESH has applications in many aspects of regenerative medicine, from wound repair to organ bioengineering, but it is just one piece of a growing biofabrication field. “Really what we’re talking about is the convergence of technologies,” says Feinberg. “Not just what my lab does in bioprinting, but also from other labs and small companies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software.”
“It is important to understand that there are many years of research yet to be done,” adds Feinberg, “but there should still be excitement that we’re making real progress towards engineering functional human tissues and organs, and this paper is one step along that path.”
Learn more: 3D printing the human heart
The Latest on: 3D bioprinting
via Google News
The Latest on: 3D bioprinting
- Future Buildings Could Be Made From 3D Printed Microbeson November 23, 2021 at 10:53 am
3D bioprinting is similar, but the ink that's used to make these materials consists of living cells that can organize into solid structures. These “bioinks,” MIT engineer and study co-author Avinash ...
- Voxel-Based Technique to Streamline Bioprintingon November 22, 2021 at 2:01 pm
At the University of Virginia researchers developed a new bioprinting technique based on voxels. Voxels are 3D cubes that form basic building blocks in computer graphics, similar to what pixels ...
- 3D Systems Expands Bioprinting Capabilitieson November 22, 2021 at 1:39 pm
D Systems’ recent acquisition of Volumetric and its continued collaboration with other biotech companies pushes 3D bioprinting capabilities into the future.
- Ebbw Vale Innovation Centre Chosen as Research Base for Biomedical Firmon November 21, 2021 at 7:55 pm
Tata Steel’s Ebbw Vale Innovation Centre has been chosen as the research and development facility for an exciting young Welsh biotech company. Copner ...
- 3D Bioprinting Market Size to Expand Significantly by the End of 2026on November 18, 2021 at 4:02 am
The 3D Bioprinting Market report has recently been added to Stratview Research’s offering. This report shows lucrative growth opportunities in the industry during the next five-year period and ...
- CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Resultson November 18, 2021 at 4:00 am
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced ...
- Global 3D Bioprinting and Bioink Market 2021 - Top Industry Players, Key Trends, Regional Markets and Recent Developments by 2027on November 17, 2021 at 8:05 pm
With this report titled Global 3D Bioprinting and Bioink Market Research Report 2021-2027, research analysts of MarketsandResearch.biz help us to present our clients with insightful data on the ...
- 3D Bioprinting Market Report for 2021 Explored in Latest Researchon November 16, 2021 at 11:59 pm
3D Bioprinting market research report has been organized with most advanced insight and analysis to give maximum benefits to the healthcare industry. The scope of this market report involves ...
- UVA researchers advance bioprintingon November 16, 2021 at 4:00 pm
Their technology uses small spherical bio-ink particles (i.e., voxels) as the basic unit to create 3D structures. DASP offers an alternative to available bioprinting techniques in which ...
via Bing News